TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Genfit
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

GENFIT and EVerZom have initiated a research collaboration to explore EViv, an innovative exosome-based regenerative therapy for Acute-On-Chronic Liver Failure (ACLF), with plans to conduct exploratory studies and potentially advance into clinical development within 18 months.

Insights
QQQ   positive

Nearly 500% total return in past decade, 19.6% average annualized return, and exposure to top tech and innovation-driven companies


GNFT   positive

Expanding research portfolio, exploring novel therapeutic mechanism, and establishing strategic partnership to advance potential treatment for liver disease